214 related articles for article (PubMed ID: 26939629)
1. A Novel Methodology for Applying Multivoxel MR Spectroscopy to Evaluate Convection-Enhanced Drug Delivery in Diffuse Intrinsic Pontine Gliomas.
Guisado DI; Singh R; Minkowitz S; Zhou Z; Haque S; Peck KK; Young RJ; Tsiouris AJ; Souweidane MM; Thakur SB
AJNR Am J Neuroradiol; 2016 Jul; 37(7):1367-73. PubMed ID: 26939629
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
3. Influence of an intratumoral cyst on drug distribution by convection-enhanced delivery: case report.
Ivasyk I; Morgenstern PF; Wembacher-Schroeder E; Souweidane MM
J Neurosurg Pediatr; 2017 Sep; 20(3):256-260. PubMed ID: 28686124
[TBL] [Abstract][Full Text] [Related]
4. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
Souweidane MM; Kramer K; Pandit-Taskar N; Zhou Z; Haque S; Zanzonico P; Carrasquillo JA; Lyashchenko SK; Thakur SB; Donzelli M; Turner RS; Lewis JS; Cheung NV; Larson SM; Dunkel IJ
Lancet Oncol; 2018 Aug; 19(8):1040-1050. PubMed ID: 29914796
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma.
Heiss JD; Jamshidi A; Shah S; Martin S; Wolters PL; Argersinger DP; Warren KE; Lonser RR
J Neurosurg Pediatr; 2018 Dec; 23(3):333-342. PubMed ID: 30544335
[TBL] [Abstract][Full Text] [Related]
6. The distribution, clearance, and brainstem toxicity of panobinostat administered by convection-enhanced delivery.
Singleton WGB; Bienemann AS; Woolley M; Johnson D; Lewis O; Wyatt MJ; Damment SJP; Boulter LJ; Killick-Cole CL; Asby DJ; Gill SS
J Neurosurg Pediatr; 2018 Sep; 22(3):288-296. PubMed ID: 29856296
[TBL] [Abstract][Full Text] [Related]
7. Clinical tolerance of corticospinal tracts in convection-enhanced delivery to the brainstem.
Morgenstern PF; Zhou Z; Wembacher-Schröder E; Cina V; Tsiouris AJ; Souweidane MM
J Neurosurg; 2018 Dec; 131(6):1812-1818. PubMed ID: 30579270
[TBL] [Abstract][Full Text] [Related]
8. Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment.
Zhou Z; Singh R; Souweidane MM
Curr Neuropharmacol; 2017; 15(1):116-128. PubMed ID: 27306036
[TBL] [Abstract][Full Text] [Related]
9. Deformational changes after convection-enhanced delivery in the pediatric brainstem.
Bander ED; Tizi K; Wembacher-Schroeder E; Thomson R; Donzelli M; Vasconcellos E; Souweidane MM
Neurosurg Focus; 2020 Jan; 48(1):E3. PubMed ID: 31896089
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
11. Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.
Anderson RC; Kennedy B; Yanes CL; Garvin J; Needle M; Canoll P; Feldstein NA; Bruce JN
J Neurosurg Pediatr; 2013 Mar; 11(3):289-95. PubMed ID: 23240851
[TBL] [Abstract][Full Text] [Related]
12. Evaluating infusate parameters for direct drug delivery to the brainstem: a comparative study of convection-enhanced delivery versus osmotic pump delivery.
Rechberger JS; Power EA; Lu VM; Zhang L; Sarkaria JN; Daniels DJ
Neurosurg Focus; 2020 Jan; 48(1):E2. PubMed ID: 31896090
[TBL] [Abstract][Full Text] [Related]
13. Repeat convection-enhanced delivery for diffuse intrinsic pontine glioma.
Bander ED; Ramos AD; Wembacher-Schroeder E; Ivasyk I; Thomson R; Morgenstern PF; Souweidane MM
J Neurosurg Pediatr; 2020 Sep; 26(6):661-666. PubMed ID: 32977309
[TBL] [Abstract][Full Text] [Related]
14. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH
J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
[TBL] [Abstract][Full Text] [Related]
15. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
16. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
17. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
18. Discrepant longitudinal volumetric and metabolic evolution of diffuse intrinsic Pontine gliomas during treatment: implications for current response assessment strategies.
Löbel U; Hwang S; Edwards A; Li Y; Li X; Broniscer A; Patay Z
Neuroradiology; 2016 Oct; 58(10):1027-1034. PubMed ID: 27438806
[TBL] [Abstract][Full Text] [Related]
19. Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.
Sewing AC; Caretti V; Lagerweij T; Schellen P; Jansen MH; van Vuurden DG; Idema S; Molthoff CF; Vandertop WP; Kaspers GJ; Noske DP; Hulleman E
J Neurosci Methods; 2014 Dec; 238():88-94. PubMed ID: 25263805
[TBL] [Abstract][Full Text] [Related]
20. Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in children with high-grade glioma and diffuse intrinsic pontine glioma: results of a phase I trial.
McCrea HJ; Ivanidze J; O'Connor A; Hersh EH; Boockvar JA; Gobin YP; Knopman J; Greenfield JP
J Neurosurg Pediatr; 2021 Aug; 28(4):371-379. PubMed ID: 34359048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
